Citi: Contemporary Amperex Technology (03750) September production may fall 3% month-on-month; short-term market sentiment is sluggish.
Citi understands that inventories continued to decline by 923 tonnes this week; if this momentum continues, the spot market may tighten in October.
Citi released a research report stating that ZE Consulting estimates Contemporary Amperex Technology's (03750) September monthly production fell 3% month-on-month, with October monthly production likely roughly flat; combined with ongoing market concerns over battery demand, especially EV battery demand, this will continue to weigh on short-term market sentiment.
According to ZE Consulting's latest production pipeline checks, battery and battery material components saw only modest mid-single-digit month-on-month growth in September monthly production, while lithium may see approximately 11% month-on-month growth. However, the bank understands that inventories continued to decline by 923 tonnes this week; if this momentum continues, the spot market may tighten in October.
Related Articles

General Manager Cheng Zhenghui of APT Medical Inc. (688617.SH) plans to reduce his shareholding by no more than 1.5%.

EFORT Intelligent Equipment (688165.SH) shareholder Xinwei Jishi and its concerted parties plan to reduce their shareholding by no more than 3%.

Shanghai Shen Lian Biomedical Corporation (688098.SH): Phase II clinical trial of UB-221 for the treatment of chronic spontaneous urticaria meets primary endpoint
General Manager Cheng Zhenghui of APT Medical Inc. (688617.SH) plans to reduce his shareholding by no more than 1.5%.

EFORT Intelligent Equipment (688165.SH) shareholder Xinwei Jishi and its concerted parties plan to reduce their shareholding by no more than 3%.

Shanghai Shen Lian Biomedical Corporation (688098.SH): Phase II clinical trial of UB-221 for the treatment of chronic spontaneous urticaria meets primary endpoint

RECOMMEND





